Single lung transplantation and pulmonary hypertension
There are few successful treatments for pulmonary hypertension. Long-term domiciliary oxygen therapy prolongs survival in patients with secondary pulmonary hypertension resulting from chronic hypoxic lung disease.' There is some evidence that the quality of life is also improved.2 For primary pulmonary hypertension, which is unexplained by cardiac or pulmonary disease, no established medical treatment, other than anticoagulant therapy increases survival.3 Vasodilatation treatment can improve the quality of life4 and early evidence from the use of long-term intravenous infusion of prostacyclin in the most severe forms of the disease suggests that survival can be increased. 5 Heart-lung transplantation has emerged as a successful treatment for a wide range of chronic end stage cardiopulmonary diseases, including pulmonary hypertension.6 It improves the survival of patients with cystic fibrosis and respiratory failure.7 In patients with pulmonary hypertension, heart-lung transplantation restores pulmonary vascular resistance to normal.8 However, the limited availability of donors with both lungs suitable for transplant surgery,9 impedes the wider use of this treatment. Indeed patients often wait for more than seven months and over a quarter die on the waiting list.
For some diseases, including lung fibrosis and emphysema, the development of single lung transplantation offers certain advantages over heart-lung transplantation.'0 It requires only one suitable lung, which may theoretically increase the supply of donor organs. Because recipients retain their own hearts, they will not experience graft related coronary occlusive disease which limits the long-term success of cardiac transplantation." Actuarial survival after single lung transplantation is approaching that after heart-lung transplantation9 so it is with special interest we learn ofthe haemodynamic effects of single lung transplantation on the treatment of pulmonary hypertension. Doig et al showed that haemodynamic function improved considerably after single lung transplantation for moderately severe pulmonary hypertension. '2 This experience encourages the wider use of single lung transplantation perhaps limiting heart-lung transplantation to patients with cystic fibrosis. It 
